Effects of Tranexamic Acid on Hemorrhage Control and Deep Venous Thrombosis Rate After Total Knee Arthroplasty: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Background: Total knee arthroplasty (TKA) surgery has a lot of complications, especially hemorrhage, which can be controlled via tranexamic acid (TXA). The guidelines endorse the integration of TXA interventions in the management of TKA-induced complications. However, uncertainty surrounds the effec...

Full description

Bibliographic Details
Main Authors: Tao Ling, Zhihu Zhao, Wenwen Xu, Weihong Ge, Lingli Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.639694/full
_version_ 1819152769033961472
author Tao Ling
Zhihu Zhao
Wenwen Xu
Weihong Ge
Lingli Huang
author_facet Tao Ling
Zhihu Zhao
Wenwen Xu
Weihong Ge
Lingli Huang
author_sort Tao Ling
collection DOAJ
description Background: Total knee arthroplasty (TKA) surgery has a lot of complications, especially hemorrhage, which can be controlled via tranexamic acid (TXA). The guidelines endorse the integration of TXA interventions in the management of TKA-induced complications. However, uncertainty surrounds the effects of different TXA therapies. This frequentist model network meta-analysis (NMA) aims to compare hemorrhage control and deep venous thrombosis (DVT) rate of different TXA therapies in TKA.Methods: Articles were searched with the PubMed, Embase, Cochrane Library, and Web of Science from 1966 to October 2020. Randomized controlled trials (RCTs) comparing different TXA therapies, or with placebo in patients with TKA were included. Two investigators independently conducted article retrievals and data collection. The outcome was total blood loss and DVT rate. Effect size measures were mean differences (MDs), or odds ratios (ORs) with 95% confidence intervals (CIs). We conducted a random-effects NMA using a frequentist approach to estimate relative effects for all comparisons and rank treatments according to the mean rank and surface under the cumulative ranking curve values. All analyses were performed in Stata software or R software. The study protocol was registered with PROSPERO, number CRD42020202404.Results: We identified 1 754 citations and included 81 studies with data for 9 987 patients with TKA. Overall, all TXA therapies were superior to placebo for total blood loss in TKA. Of all TXA therapies, M therapy (IV/IV infusion + oral TXA > 3g) was most effective for total blood loss (MD=−688.48, −1084.04–−328.93), followed by F therapy (IV TXA ≥ 15 mg/kg or 1 g three times). TXA therapies in this study are not associated with the increase of DVT risk.Conclusions: TXA therapies in this study are effective and safe for the treatment of TKA-induced complications. M therapy (IV/IV infusion + oral TXA > 3 g) may be the most effective TXA therapy for hemorrhage control. TXA therapies in this study do not increase DVT risk. Considering hemorrhage control and DVT rate simultaneously, F therapy (IV TXA ≥ 15 mg/kg or 1 g three times) may be suggested to apply for TKA, and this study may provide a crucial clue to future TXA use.
first_indexed 2024-12-22T14:54:33Z
format Article
id doaj.art-579438dbd1184417b589911dd54b04c5
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-22T14:54:33Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-579438dbd1184417b589911dd54b04c52022-12-21T18:22:15ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-07-011210.3389/fphar.2021.639694639694Effects of Tranexamic Acid on Hemorrhage Control and Deep Venous Thrombosis Rate After Total Knee Arthroplasty: A Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsTao Ling0Zhihu Zhao1Wenwen Xu2Weihong Ge3Lingli Huang4Department of Pharmacy, Suqian First Hospital, Suqian, ChinaDepartment of Orthopaedics, Tianjin Hospital, Tianjin, ChinaDepartment of Neurology, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, ChinaDepartment of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, ChinaDepartment of Pharmacy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, ChinaBackground: Total knee arthroplasty (TKA) surgery has a lot of complications, especially hemorrhage, which can be controlled via tranexamic acid (TXA). The guidelines endorse the integration of TXA interventions in the management of TKA-induced complications. However, uncertainty surrounds the effects of different TXA therapies. This frequentist model network meta-analysis (NMA) aims to compare hemorrhage control and deep venous thrombosis (DVT) rate of different TXA therapies in TKA.Methods: Articles were searched with the PubMed, Embase, Cochrane Library, and Web of Science from 1966 to October 2020. Randomized controlled trials (RCTs) comparing different TXA therapies, or with placebo in patients with TKA were included. Two investigators independently conducted article retrievals and data collection. The outcome was total blood loss and DVT rate. Effect size measures were mean differences (MDs), or odds ratios (ORs) with 95% confidence intervals (CIs). We conducted a random-effects NMA using a frequentist approach to estimate relative effects for all comparisons and rank treatments according to the mean rank and surface under the cumulative ranking curve values. All analyses were performed in Stata software or R software. The study protocol was registered with PROSPERO, number CRD42020202404.Results: We identified 1 754 citations and included 81 studies with data for 9 987 patients with TKA. Overall, all TXA therapies were superior to placebo for total blood loss in TKA. Of all TXA therapies, M therapy (IV/IV infusion + oral TXA > 3g) was most effective for total blood loss (MD=−688.48, −1084.04–−328.93), followed by F therapy (IV TXA ≥ 15 mg/kg or 1 g three times). TXA therapies in this study are not associated with the increase of DVT risk.Conclusions: TXA therapies in this study are effective and safe for the treatment of TKA-induced complications. M therapy (IV/IV infusion + oral TXA > 3 g) may be the most effective TXA therapy for hemorrhage control. TXA therapies in this study do not increase DVT risk. Considering hemorrhage control and DVT rate simultaneously, F therapy (IV TXA ≥ 15 mg/kg or 1 g three times) may be suggested to apply for TKA, and this study may provide a crucial clue to future TXA use.https://www.frontiersin.org/articles/10.3389/fphar.2021.639694/fulltotal knee arthroplastynetwork meta-analysistotal blood lossdeep vein thrombosistranexamic acid
spellingShingle Tao Ling
Zhihu Zhao
Wenwen Xu
Weihong Ge
Lingli Huang
Effects of Tranexamic Acid on Hemorrhage Control and Deep Venous Thrombosis Rate After Total Knee Arthroplasty: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Frontiers in Pharmacology
total knee arthroplasty
network meta-analysis
total blood loss
deep vein thrombosis
tranexamic acid
title Effects of Tranexamic Acid on Hemorrhage Control and Deep Venous Thrombosis Rate After Total Knee Arthroplasty: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
title_full Effects of Tranexamic Acid on Hemorrhage Control and Deep Venous Thrombosis Rate After Total Knee Arthroplasty: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
title_fullStr Effects of Tranexamic Acid on Hemorrhage Control and Deep Venous Thrombosis Rate After Total Knee Arthroplasty: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
title_full_unstemmed Effects of Tranexamic Acid on Hemorrhage Control and Deep Venous Thrombosis Rate After Total Knee Arthroplasty: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
title_short Effects of Tranexamic Acid on Hemorrhage Control and Deep Venous Thrombosis Rate After Total Knee Arthroplasty: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
title_sort effects of tranexamic acid on hemorrhage control and deep venous thrombosis rate after total knee arthroplasty a systematic review and network meta analysis of randomized controlled trials
topic total knee arthroplasty
network meta-analysis
total blood loss
deep vein thrombosis
tranexamic acid
url https://www.frontiersin.org/articles/10.3389/fphar.2021.639694/full
work_keys_str_mv AT taoling effectsoftranexamicacidonhemorrhagecontrolanddeepvenousthrombosisrateaftertotalkneearthroplastyasystematicreviewandnetworkmetaanalysisofrandomizedcontrolledtrials
AT zhihuzhao effectsoftranexamicacidonhemorrhagecontrolanddeepvenousthrombosisrateaftertotalkneearthroplastyasystematicreviewandnetworkmetaanalysisofrandomizedcontrolledtrials
AT wenwenxu effectsoftranexamicacidonhemorrhagecontrolanddeepvenousthrombosisrateaftertotalkneearthroplastyasystematicreviewandnetworkmetaanalysisofrandomizedcontrolledtrials
AT weihongge effectsoftranexamicacidonhemorrhagecontrolanddeepvenousthrombosisrateaftertotalkneearthroplastyasystematicreviewandnetworkmetaanalysisofrandomizedcontrolledtrials
AT linglihuang effectsoftranexamicacidonhemorrhagecontrolanddeepvenousthrombosisrateaftertotalkneearthroplastyasystematicreviewandnetworkmetaanalysisofrandomizedcontrolledtrials